RIVOLTA, ILARIA
 Distribuzione geografica
Continente #
NA - Nord America 11.578
EU - Europa 6.252
AS - Asia 5.057
SA - Sud America 828
AF - Africa 95
Continente sconosciuto - Info sul continente non disponibili 17
OC - Oceania 9
Totale 23.836
Nazione #
US - Stati Uniti d'America 11.267
SG - Singapore 1.813
IT - Italia 1.551
CN - Cina 1.364
DE - Germania 1.173
RU - Federazione Russa 820
HK - Hong Kong 780
BR - Brasile 691
SE - Svezia 613
IE - Irlanda 528
VN - Vietnam 510
UA - Ucraina 346
GB - Regno Unito 342
CA - Canada 239
FI - Finlandia 205
AT - Austria 154
IN - India 142
FR - Francia 113
DK - Danimarca 102
ID - Indonesia 77
PL - Polonia 61
TR - Turchia 56
NL - Olanda 55
AR - Argentina 51
ES - Italia 50
BE - Belgio 49
MX - Messico 49
KR - Corea 47
BD - Bangladesh 43
ZA - Sudafrica 42
JP - Giappone 40
IQ - Iraq 36
EC - Ecuador 30
PK - Pakistan 24
IR - Iran 17
RO - Romania 15
BG - Bulgaria 14
CO - Colombia 14
EU - Europa 14
SA - Arabia Saudita 14
UZ - Uzbekistan 14
AE - Emirati Arabi Uniti 13
CH - Svizzera 13
CL - Cile 11
LT - Lituania 11
MA - Marocco 10
PY - Paraguay 10
VE - Venezuela 9
AZ - Azerbaigian 8
TN - Tunisia 8
JO - Giordania 7
AL - Albania 6
CZ - Repubblica Ceca 6
GE - Georgia 6
KE - Kenya 6
UY - Uruguay 6
AU - Australia 5
CX - Isole del Natale 5
DZ - Algeria 5
EG - Egitto 5
NP - Nepal 5
PH - Filippine 5
PT - Portogallo 5
SN - Senegal 5
TH - Thailandia 5
ET - Etiopia 4
HN - Honduras 4
IL - Israele 4
NG - Nigeria 4
RS - Serbia 4
SC - Seychelles 4
TT - Trinidad e Tobago 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BH - Bahrain 3
BY - Bielorussia 3
MY - Malesia 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
PA - Panama 3
SK - Slovacchia (Repubblica Slovacca) 3
BO - Bolivia 2
DO - Repubblica Dominicana 2
GR - Grecia 2
HU - Ungheria 2
JM - Giamaica 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LB - Libano 2
NO - Norvegia 2
OM - Oman 2
PE - Perù 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BS - Bahamas 1
CG - Congo 1
CR - Costa Rica 1
DM - Dominica 1
EE - Estonia 1
GA - Gabon 1
Totale 23.823
Città #
Ann Arbor 2.122
Singapore 1.116
Ashburn 948
Woodbridge 885
Frankfurt am Main 799
Hong Kong 779
Chandler 734
Fairfield 722
Wilmington 526
Dublin 515
Houston 484
Milan 412
Dallas 353
Jacksonville 336
Dearborn 310
New York 303
Santa Clara 293
Seattle 267
Cambridge 214
Beijing 208
Princeton 198
Los Angeles 154
Munich 151
Ho Chi Minh City 144
Nanjing 142
Vienna 138
Rome 129
Hefei 111
Shanghai 110
Helsinki 102
The Dalles 100
Moscow 85
Lawrence 80
Buffalo 79
São Paulo 73
Hanoi 72
Altamura 69
Guangzhou 69
Toronto 69
Chicago 64
Jakarta 62
Lachine 54
San Diego 48
Dong Ket 46
Nanchang 44
Council Bluffs 42
Brussels 41
Seoul 41
Fremont 39
London 39
Ottawa 39
Boardman 37
Andover 35
Denver 35
Montreal 32
Brooklyn 30
Changsha 29
Shenyang 29
Tokyo 29
Kraków 27
Tianjin 27
Turku 27
Warsaw 27
Bari 25
Bergamo 25
Chennai 25
Falls Church 25
Orem 25
Pune 25
Nuremberg 24
Rio de Janeiro 24
Zhengzhou 24
Columbus 23
Johannesburg 23
Jinan 22
Haiphong 21
Poplar 21
Norwalk 20
Phoenix 20
San Jose 20
Verona 20
Washington 20
Hebei 19
Edmonton 18
Stockholm 18
Atlanta 17
Bologna 16
Brasília 16
Turin 16
Belo Horizonte 15
Jiaxing 15
Mexico City 15
Taizhou 15
Brugherio 14
Da Nang 14
Kent 14
Kiev 14
Kunming 14
Manchester 14
Monza 14
Totale 16.034
Nome #
Vander Fisiologia 625
Innovative and Efficient Oral Delivery Method of APOA-1Milano Muteins Which Retain Anti-Atherosclerotic and Anti-Inflammatory Properties 465
Cardiac and neuronal HCN channelopathies 436
APOA-1Milano muteins, orally delivered via genetically modified rice, show anti-atherogenic and anti-inflammatory properties in vitro and in Apoe −/− atherosclerotic mice 417
Simultaneous overexpression of human E5NT and ENTPD1 protects porcine endothelial cells against H2O2-induced oxidative stress and cytotoxicity in vitro 389
Two novel SCN5A loss-of-function mutations affect patients with severe arrhytmogenic syndromes 386
Effect of the ketogenic diet in excitable tissues 378
Modulation of the intrinsic neuronal excitability by multifunctional liposomes tailored for treatment of Alzheimer’s disease 363
Simultaneous overexpression of functional human HO-1, E5NT and ENTPD1 protects murine fibroblasts against TNF-α-induced injury in vitro 359
HCN ion channels and accessory proteins in epilepsy: genetic analysis of a large cohort of patients and review of the literature 356
Evaluation of gold nanoparticles biocompatibility: a multiparametric study on cultured endothelial cells and macrophages 348
Hypoxia-induced modifications in plasma membranes and lipid microdomains in A549 cells and primary human alveolar cells 336
Binary biocompatible CNCs-Gelatine hydrogel as 3D scaffolds suitable for cell culture adhesion and growth 334
A novel KCNJ2 mutation identified in an autistic proband affects the single channel properties of Kir2.1 333
Respiratory Mechanics and Fluid Dynamics After Lung Resection Surgery 332
Gabapentin treatment in a patient with KCNQ2 developmental epileptic encephalopathy 322
Tissue specificity of mitochondrial adaptations in rats after 4 weeks of normobaric hypoxia 320
Progressive epileptic encephalopathy associated with a novel HCN2 mutation 314
Brugada syndrome genetics is associated with phenotype severity 308
Iron oxide nanoparticles surface coating and cell uptake affect biocompatibility and inflammatory responses of endothelial cells and macrophages 298
Interstitial pressure and lung oedema in chronic hypoxia 295
Cardiopulmonary Consequences of Post Thoracic Surgery Pulmonary Hypertension: Cause or Consequence of Lung Edema? 282
SCN4A mutation as modifying factor of Myotonic Dystrophy Type 2 phenotype 279
Role of the Air-Blood Barrier Phenotype in Lung Oxygen Uptake and Control of Extravascular Water 275
Hepcidin regulation in a mouse model of acute hypoxia 274
SCN4A as modifier gene in patients with myotonic dystrophy type 2 274
Glutamate transporters in platelets: EAAT1 decrease in aging and in Alzheimer's disease 273
From morphological heterogeneity at alveolar level to the overall mechanical lung behavior: an in vivo microscopic imaging study 269
Effect of nanoparticles binding ß-amyloid peptide on nitric oxide production by cultured endothelial cells and macrophages 265
Do the functional properties of HCN1 mutants correlate with the clinical features in epileptic patients? 264
Innovative therapies and nanomedicine applications for the treatment of alzheimer’s disease: A state-of-the-art (2017–2020) 260
Changes in the mechanical properties of the respiratory system during the development of interstitial lung edema 259
How ketogenic diet may be beneficial in controlling neuronal excitability? 252
JMV5656, a novel derivative of TLQP-21, triggers the activation of a calcium-dependent potassium outward current in microglial cells 250
Oxygen-loaded nanodroplets effectively abrogate hypoxia dysregulating effects on secretion of MMP-9 and TIMP-1 by human monocytes 249
Pharmacological and Biochemical Characterization of TLQP-21 Activation of a Binding Site on CHO Cells 248
The effect of nanoparticle uptake on cellular behavior: disrupting or enabling functions? 243
Novel SCN5A p.Val1667Asp Missense Variant Segregation and Characterization in a Family with Severe Brugada Syndrome and Multiple Sudden Deaths 243
Study of the effects of nanoliposomes engineered for the treatment of Alzheimer's disease on the electrical activity of cortical neurons 242
GSTM3 variant is a novel genetic modifier in Brugada syndrome, a disease with risk of sudden cardiac death 241
Cardiac voltage-gated sodium channel Nav1.5 is regulated by Nedd4-2 mediated ubiquitination 238
Accumulative Difference Image Protocol for Particle Tracking in Fluorescence Microscopy Tested in Mouse Lymphonodes 236
mRNA expression profile of selected oxygen sensing genes in the lung during recovery from chronic hypoxia 236
Gold Branched Nanoparticles for Cellular Treatments 230
The expression of the rare caveolin-3 variant T78M alters cardiac ion channels function and membrane excitability 230
A biophysical model of intracellular distribution and perinuclear accumulation of particulate matter 228
Dynamic Investigation of Interaction of Biocompatible Iron Oxide Nanoparticles with Epithelial Cells for Biomedical Applications 226
Dietary nanoparticles interact with gluten peptides and alter the intestinal homeostasis increasing the risk of celiac disease 223
2H,3H-decafluoropentane-based nanodroplets: New perspectives for oxygen delivery to hypoxic cutaneous tissues 222
Automated Patch-Clamp and Induced Pluripotent Stem Cell-Derived Cardiomyocytes: A Synergistic Approach in the Study of Brugada Syndrome 218
HCN1 novel mutations in familiar generalized epilepsy 217
An outlook on the potential of Si nanocrystals as luminescent probes for bioimaging 215
Acetylation mediates Cx43 reduction caused by electrical stimulation 212
A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene 211
Nav1.5 E1053K mutation causing Brugada syndrome blocks binding to ankyrin-G and expression of Nav1.5 on the surface of cardiomyocytes 208
Rational design of a mutation to investigate the role of the brain protein TRIP8b in limiting the cAMP response of HCN channels in neurons 208
Identification and functional characterisation of a new KCNJ2 mutation 207
Lipid-based nanoparticles (NPs) with high binding affinity for amyloid-beta1-42 peptide modulate the barrier properties of a monolayer of endothelial cells 203
Genetics of Long QT, Brugada, and Other Channelopathies 201
Remodelling of Membrane Rafts Expression in Lung Cells as an Early Sign of Mechanotransduction-Signalling in Pulmonary Edema 201
Alveolar mechanics studied by in vivo microscopy imaging through intact pleural space 201
HCN1 mutation spectrum: From neonatal epileptic encephalopathy to benign generalized epilepsy and beyond 201
Computer simulation of wild-type and mutant human cardiac Na+ current 198
A novel de novo HCN2 loss-of-function variant causing developmental and epileptic encephalopathy treated with a ketogenic diet 195
Experimental model to evaluate the effect of hydrothorax and lobar resection on lung compliance 195
‘In Vitro’, ‘In Vivo’ and ‘In Silico’ Investigation of the Anticancer Effectiveness of Oxygen-Loaded Chitosan-Shelled Nanodroplets as Potential Drug Vector 194
Cardiac histological substrate in patients with clinical phenotype of Brugada syndrome 193
The effect of exogenous surfactant on alveolar interdependence 189
Dextran-shelled oxygen-loaded nanodroplets reestablish a normoxia-like pro-angiogenic phenotype and behavior in hypoxic human dermal microvascular endothelium 188
Chitosan-shelled oxygen-loaded nanodroplets abrogate hypoxia dysregulation of human keratinocyte gelatinases and inhibitors: New insights for chronic wound healing 188
Functional Characterization of Two Variants at the Intron 6-Exon 7 Boundary of the KCNQ2 Potassium Channel Gene Causing Distinct Epileptic Phenotypes 184
Cellular uptake of coumarin-6 as a model drug loaded in solid lipid nanoparticles 183
A novel de novo HCN1 loss-of-function mutation in genetic generalized epilepsy causing increased neuronal excitability 182
A novel KCNC1 gain-of-function variant causing developmental and epileptic encephalopathy: "Precision medicine" approach with fluoxetine 181
T-Type Calcium Channels: A Mixed Blessing 180
Ion Channel as Target for Drugs 178
Invitro- Invivo fluctuation spectroscopies 177
Regional Differences in the protein patterns related to lung remodeling and oxygen sensing 175
Alterations of the Sialylation Machinery in Brugada Syndrome 171
BS-499656-002 Lethal Autoimmune Channelopathies: Nav1.5 Autoantibodies And Their Role In Sudden Cardiac Death 170
Silica encapsulation of luminescent silicon nanoparticles: Stable and biocompatible nanohybrids 168
Unravelling Novel SCN5A Mutations Linked to Brugada Syndrome: Functional, Structural, and Genetic Insights 158
Cardiac sodium channel diseases 155
Bio-medical and sensor application of silicon nanoparticles 153
NaV1.5 autoantibodies in Brugada syndrome: pathogenetic implications 151
Novel arrhythmogenic mechanism revealed by a long-QT syndrome mutation in the cardiac Na(+) channel 151
Nanoparticles modulate the stability of the nuclear structure interfering in the mechanical connection between plasma membrane and nucleus 151
SCN4A as modifier gene in myotonic dystrophy type 2 (DM2) patients with early and severe myotonia 151
Cellular interaction with Si- and Iron-based nanoparticles for bio-imaging. A study of biocompatibility (Conference Paper ) 150
Fisiologia Medica - Terza Edizione 148
Giovanni Alfonso Borelli, Giorgio Baglivi, and the origin of the heartbeat in the seventeenth century 146
Mechanistic considerations on the development of lung edema: Vascular, perivascular and molecular aspects from early stage to tissue and vascular remodeling stage 146
Ion channels in the heart 145
In silico assessment of Y1795C and Y1795H SCN5A mutations: implication for inherited arrhythmogenic syndromes 140
Markovian model for wild-type and mutant (Y1795C and Y1795H) human cardiac Na/sup +/ channel 140
Vander Fisiologia 139
Comparative expression of two oxygen-dependent transcription factors (O2TF) in lungs, heart and skeletal muscles in a rat model of chronic hypoxia (CH) 134
Modulation of cardiac sodium channel gating by protein kinase A can be altered by disease-linked mutation 132
Advances in the preparation of novel functionalized nanoparticles for bioimaging 126
A rabbit model of uremia-induced cardiomyopathy 126
Totale 23.659
Categoria #
all - tutte 79.001
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.001


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.507 0 0 0 0 0 211 254 195 197 226 168 256
2021/20221.589 143 180 164 153 72 120 95 78 63 112 123 286
2022/20232.945 321 865 342 302 208 431 24 133 191 25 55 48
2023/20241.833 56 64 84 127 232 473 337 52 137 48 27 196
2024/20254.214 225 424 168 284 385 245 228 202 444 611 315 683
2025/20265.508 1.097 502 928 1.223 1.288 470 0 0 0 0 0 0
Totale 24.746